Will AbbVie-Shire Deal Come Together by Deadline?

July 18 (Bloomberg) -- Naresh Chouhan, head of European pharma research at Liberum Capital, discusses today’s deadline for a deal between AbbVie and Shire and how U.S. tax law is impacting pharmaceutical deals. He speaks with Jonathan Ferro on “On The Move.”

UBS's Hayden Briscoe Has Positive Outlook for Bonds
02:36 - Hayden Briscoe, UBS Asset Management head of fixed income for Asia-Pacific, discusses the outlook for Fed policy, commodities and bonds with Bloomberg's Stephen Engle and Haidi Lun on "Bloomberg Markets." (Source: Bloomberg)
  • S&P Says Toshiba May Be Cut Further
  • Hoover Inst.'s Chen Says Trump Still Has a Lot to Learn
  • Full Show: What'd You Miss? (03/28)